From Breakthrough to Blockbuster: The Business of Biotechnology (Guest: Donald L. Drakeman)

Published January 12, 2023
Heartland’s Tim Benson is joined by Donald L. Drakeman, Fellow in Operations and Technology Management at the Cambridge Judge Business School, Distinguished Research Professor in the Program on Constitutional Studies at the University of Notre Dame, and a Venture Partner at Advent Life Sciences, to discuss his new book (co-authored with Lisa Drakeman and Nektarios Oraiopoulos), From Breakthrough to Blockbuster: The Business of Biotechnology. They chat about how medical innovation happens, specifically how biotech companies have created 40 percent more of the most important treatments for previously unmet medical needs than the major pharmaceutical companies at a lower cost. Benson and Drakeman also discuss the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and the pharmaceutical companies in creating medical breakthroughs.